Dr. Michael Lioudis, MD

Dr. Lioudis practices at Upstate University Hospital in Syracuse, New York, part of State University of New York.

Dr. Lioudis' NPI, 1073729463, was assigned on May 15, 2007. Dr. Lioudis graduated from State University of New York at Buffalo School of Medicine in 1999. Dr. Lioudis holds New York license 310114.

Dr. Lioudis' primary practice is Upstate University Hospital, at 750 East Adams Street, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 473-4240.

Dr. Lioudis' primary practice is Upstate University Hospital in Syracuse, New York, part of State University of New York. The medical group on file is Department of Medicine. Dmand AI also links Dr. Lioudis to 2 more medical groups, 1 group practice or clinic and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lioudis practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Lioudis' primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Lioudis is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Lioudis' licenses on file in 2 states: New York and Pennsylvania.

CMS data shows 355 Medicare services from Dr. Lioudis across 5 procedure codes in 2024, for 184 Medicare patients. Medicare paid $33,860 for them.

CMS counts 184 Medicare patients who saw Dr. Lioudis in 2024. The largest group is under 65, with 61 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 39% are also on Medicaid. Their average risk score is 6.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lioudis' median patient age at 64, with 44% women.

In 2021, Dr. Lioudis wrote 281 Medicare Part D claims. They cover 13 drugs, with $10,543 in total drug cost. In 2020, CMS named 406 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Lioudis for performance year 2024, reported as part of a group. Dr. Lioudis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Lioudis, published from 2016 to 2023. 2018 was the busiest year, with 3. The most frequent topics are Nephrectomy, Robotic Surgical Procedures and Blood Pressure Determination. Dr. Lioudis' most frequent co-authors are William Chandler Cushman, MD, Emilio D. Poggio, MD and Janet Adegboye, MD.

Dmand AI links Dr. Lioudis to 1 clinical trial. Conditions studied include Polycystic Kidney, Autosomal Dominant and Polycystic Kidney Diseases. Open Payments lists research payments to Dr. Lioudis that name 1 trial.

CMS Open Payments shows 31 general payments to Dr. Lioudis from 6 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 92% of the total. Otsuka Pharmaceutical Development & Commercialization, Inc. paid the most, $27,352. It also lists 1 research payment totaling $123 in 2017, naming 1 clinical trial.

Dr. Lioudis graduated from State University of New York at Buffalo School of Medicine in 1999.